2021 annual financial data
Relmada Therapeutics 2021 Operating cash flow
Direct answer
Operating cash flow was -91,873,395 USD.
Operating income was -125,703,492 USD and net income was -125,751,809 USD.
Operating cash flow was -91,873,395 USD.
Get free Relmada Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -125,703,492 USD
- Net income
- -125,751,809 USD
- Operating cash flow
- -91,873,395 USD